Full Breakdown
Impact of the Iran War on Rubber Glove Prices and Healthcare Supply Chains
4/18/2026, 2:55:16 AM
Rising Prices and Supply Concerns
The ongoing conflict in Iran has significantly disrupted the supply chains for rubber glove manufacturers, leading to sharp price increases and warnings of potential production cuts. Analysts from CIMB Securities report that the average price of synthetic rubber gloves has surged by approximately 40%, reaching as high as $29 for a box of 1,000 gloves. This spike is primarily attributed to soaring naphtha prices, a by-product of crude oil refining essential for producing plastics and petrochemicals. The closure of the Strait of Hormuz, a critical shipping route for global oil and gas, has exacerbated these price increases.
Healthcare Sector on Alert
Dr. Kuljit Singh, president of the Association of Private Hospitals of Malaysia, emphasized the critical role gloves play in medical procedures, stating, "If there is a shortage, this means there will be some difficulty to deliver some services in the healthcare sector." While hospitals currently maintain adequate supplies, they are closely monitoring the situation, as sustained disruptions could lead to shortages by late May, according to analysts from RHB and CIMB Securities.
Manufacturer Responses and Market Reactions
Top Glove, the world's largest glove manufacturer, has indicated plans to pass on cost increases of about 50% for raw materials, particularly nitrile latex, which constitutes around 55% of its glove production. Hartalega Holdings CEO Kuan Mun Leong confirmed that glove prices have already been adjusted in response to rising input costs and expressed concerns about the long-term impact of the conflict on global glove supply. Additionally, companies like Medtecs, which produces medical equipment, have raised prices by 10% to 40% depending on the product.
Shares of Top Glove and Hartalega have seen significant increases, climbing approximately 40% and 50%, respectively, between March 24 and April 10. However, analysts from RHB caution that these gains may be unsustainable, attributing the current environment to a cost-push inflation cycle rather than a demand-driven upcycle.
Criticism and Market Outlook
Despite the immediate price adjustments, analysts warn that the current price hikes are defensive measures aimed at preserving profit margins rather than expanding them. The healthcare sector remains cautious, balancing the need for immediate supplies against the risk of prolonged shortages. As geopolitical tensions continue to affect essential healthcare services, the industry braces for further price increases and potential supply challenges.
Verbatim Quotes
- “If there is a shortage, this means there will be some difficulty to deliver some services in the healthcare sector,” — Dr. Kuljit Singh, President, Association of Private Hospitals of Malaysia
- “glove prices have been adjusted accordingly” — Kuan Mun Leong, CEO, Hartalega Holdings
- “The current environment is a cost-push inflation cycle, not a demand-driven upcycle,” — RHB Analysts
The situation underscores the fragility of global supply chains and the far-reaching impacts of geopolitical conflicts on essential industries.
